blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3125900

EP3125900 - TREATMENT OF COGNITIVE DISORDERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.12.2017
Database last updated on 13.09.2024
FormerRequest for examination was made
Status updated on  06.01.2017
FormerThe international publication has been made
Status updated on  28.11.2016
Most recent event   Tooltip15.12.2017Application deemed to be withdrawnpublished on 17.01.2018  [2018/03]
Applicant(s)For all designated states
Algiax Pharmaceuticals GmbH
Max-Planck-Straße 15a
40699 Erkrath / DE
[2017/06]
Inventor(s)01 / KOOPMANS, Guido
Algiax Pharmaceuticals GmbH
Max-Planck-Strasse 15a
40699 Erkrath / DE
02 / HASSE, Birgit
Algiax Pharmaceuticals GmbH
Max-Planck-Strasse 15a
40699 Erkrath / DE
 [2017/06]
Representative(s)Roth, Andy Stefan
Dr. Roth Patentanwaltskanzlei
Kaistrasse 5
40221 Düsseldorf / DE
[N/P]
Former [2017/06]Roth, Andy Stefan
Dr. Roth Patentanwaltskanzlei
Columbusstrasse 22
40549 Düsseldorf / DE
Application number, filing date15711187.320.03.2015
[2017/06]
WO2015EP55989
Priority number, dateEP2014000115028.03.2014         Original published format: EP 14001150
US201461971799P28.03.2014         Original published format: US 201461971799 P
[2017/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015144598
Date:01.10.2015
Language:EN
[2015/39]
Type: A1 Application with search report 
No.:EP3125900
Date:08.02.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 01.10.2015 takes the place of the publication of the European patent application.
[2017/06]
Search report(s)International search report - published on:EP01.10.2015
ClassificationIPC:A61K31/53, A61K31/27, A61K31/445, A61K31/06, A61P25/00, A61P25/28, A61P43/00
[2017/06]
CPC:
A61K31/53 (EP,US); A61K31/27 (EP,US); A61K31/445 (EP,US);
A61K45/06 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P43/00 (EP) (-)
C-Set:
A61K31/27, A61K2300/00 (US,EP);
A61K31/445, A61K2300/00 (US,EP);
A61K31/53, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/06]
TitleGerman:BEHANDLUNG VON KOGNITIVEN STÖRUNGEN[2017/06]
English:TREATMENT OF COGNITIVE DISORDERS[2017/06]
French:TRAITEMENT DE TROUBLES COGNITIFS[2017/06]
Entry into regional phase13.09.2016National basic fee paid 
13.09.2016Designation fee(s) paid 
13.09.2016Examination fee paid 
Examination procedure13.09.2016Examination requested  [2017/06]
13.09.2016Date on which the examining division has become responsible
25.07.2017Application deemed to be withdrawn, date of legal effect  [2018/03]
30.08.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2018/03]
Fees paidPenalty fee
Additional fee for renewal fee
31.03.201703   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO02098879  (BAYER AG [DE], et al) [X] 1-4,7-9,11,12,14 * examples 7,8; claims 1-3 * * page 14, line 29 * * page 14, lines 4-8 * [Y] 1-14 [I] 6;
 [XY]WO2012123406  (ALGIAX PHARMACEUTICALS GMBH [DE], et al) [X] 1-9,11-14 * abstract * * page 8, lines 10-16 * * page 12, lines 12-14 * [Y] 10;
 [Y]EP2116240  (COLD SPRING HARBOR LAB [US]) [Y] 1-14 * abstract *;
 [Y]EP1203584  (M D M S R L [IT]) [Y] 10 * abstract *;
 [Y]WO2006135828  (MEMORY PHARM CORP [US], et al) [Y] 10 * abstract *;
 [A]US2004097498  (NIEWOHNER ULRICH [DE], et al) [A] 1-14 * abstract * * paragraph [0404] *
 [Y]  - JACOBSEN F M ET AL, "DONEPEZIL FOR PSYCHOTROPIC-INDUCED MEMORY LOSS", JOURNAL OF CLINICAL PSYCHIATRY, PHYSICIANS POSTGRADUATE PRESS, INC, US, (19991001), vol. 60, no. 10, ISSN 0160-6689, pages 698 - 704, XP000892626 [Y] 10 * abstract *
 [Y]  - LISA Y M CHUAH ET AL, "Memory effects of Donepezil During sleep Deprivation - Donepezil Improves Episodic Memory in Young Individuals Vulnerable to the Effects of Sleep Deprivation", SLEEP COGNITIVE NEUROSCIENCE LAB 2009, (20090101), vol. 32, no. 8, pages 999 - 1010, XP055189294 [Y] 10 * abstract *
 [Y]  - DIMITROVA D ET AL, "P.5.b.004 Comparative study of the effects of tacrine, donepezil and galantamine on scopolamine-induced impaired memory in rats", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 19, ISSN 0924-977X, (20090901), pages S626 - S627, (20090901), XP026795689 [Y] 10 * abstract *
 [Y]  - "P.5.010 Effects of rivastigmine on learning and short memory retention in rats with hypoxia-induced model of amnesia", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 15, ISSN 0924-977X, (20050101), pages S561 - S562, (20050101), XP027808948 [Y] 10 * abstract *
 [Y]  - WEZENBERG E ET AL, "Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects", PSYCHOPHARMACOLOGY, SPRINGER, BERLIN, DE, (20050901), vol. 181, no. 3, doi:10.1007/S00213-005-0083-7, ISSN 1432-2072, pages 582 - 594, XP019326595 [Y] 10 * abstract *

DOI:   http://dx.doi.org/10.1007/s00213-005-0083-7
 [Y]  - MARTINEZ-CORIA H ET AL, "P.5.b.005 Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with Alzheimer-type pathology", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 19, ISSN 0924-977X, (20090901), page S627, (20090901), XP026795690 [Y] 10 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.